143 related articles for article (PubMed ID: 38372406)
1. Meta-analysis: Risk of pancreatic cancer in patients with inflammatory bowel disease.
Zamani M; Alizadeh-Tabari S; Murad MH; Ananthakrishnan AN; Malekzadeh R; Talley NJ
Aliment Pharmacol Ther; 2024 Apr; 59(8):918-927. PubMed ID: 38372406
[TBL] [Abstract][Full Text] [Related]
2. The risk of rheumatoid arthritis among patients with inflammatory bowel disease: a systematic review and meta-analysis.
Chen Y; Chen L; Xing C; Deng G; Zeng F; Xie T; Gu L; Yang H
BMC Gastroenterol; 2020 Jun; 20(1):192. PubMed ID: 32552882
[TBL] [Abstract][Full Text] [Related]
3. A systematic review and meta-analysis of prospective studies on obesity and risk of inflammatory bowel disease.
Milajerdi A; Abbasi F; Esmaillzadeh A
Nutr Rev; 2022 Feb; 80(3):479-487. PubMed ID: 34157115
[TBL] [Abstract][Full Text] [Related]
4. Causal Association Between Inflammatory Bowel Disease and Psoriasis: A Two-Sample Bidirectional Mendelian Randomization Study.
Li Y; Guo J; Cao Z; Wu J
Front Immunol; 2022; 13():916645. PubMed ID: 35757704
[TBL] [Abstract][Full Text] [Related]
5. Increased risk of stroke among patients with inflammatory bowel disease: A PRISMA-compliant meta-analysis.
Chen Y; Wang X
Brain Behav; 2021 Jun; 11(6):e02159. PubMed ID: 33960728
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory bowel disease increases the risk of hepatobiliary pancreatic cancer: A two-sample Mendelian randomization analysis of European and East Asian populations.
Huang J; Li X; Hong J; Huang L; Jiang Q; Guo S; Rong Y; Guo G
Cancer Med; 2023 Jun; 12(12):13599-13609. PubMed ID: 37184160
[TBL] [Abstract][Full Text] [Related]
7. Causal association between inflammatory bowel disease and hidradenitis suppurativa: A two-sample bidirectional Mendelian randomization study.
Bao B; Zhu C; Shi J; Lu C
Front Immunol; 2023; 14():1071616. PubMed ID: 36776852
[TBL] [Abstract][Full Text] [Related]
8. Association between inflammatory bowel disease and risk of incident prostate cancer: a systematic review and meta-analysis of cohort studies.
Zhou BG; Yu Q; Jiang X; Mei YZ; Ding YB; Wang M
Int J Colorectal Dis; 2023 Jun; 38(1):168. PubMed ID: 37310514
[TBL] [Abstract][Full Text] [Related]
9. Risk of Cervical Cancer in Inflammatory Bowel Disease: A Meta-Analysis of Population-Based Studies.
Mann S; Jess T; Allin K; Elmahdi R
Clin Transl Gastroenterol; 2022 Jul; 13(7):e00513. PubMed ID: 35905421
[TBL] [Abstract][Full Text] [Related]
10. Development of Cancer Among Patients With Pediatric-Onset Inflammatory Bowel Disease: A Meta-analysis of Population-Based Studies.
Elmahdi R; Lemser CE; Thomsen SB; Allin KH; Agrawal M; Jess T
JAMA Netw Open; 2022 Mar; 5(3):e220595. PubMed ID: 35230438
[TBL] [Abstract][Full Text] [Related]
11. Risk of uterine cervical cancer in inflammatory bowel disease: a systematic review and meta-analysis.
Kim J; Jung JH; Jo H; Kim MH; Kang DR; Kim HM
Scand J Gastroenterol; 2023; 58(12):1412-1421. PubMed ID: 37517000
[TBL] [Abstract][Full Text] [Related]
12. Association between inflammatory bowel disease and frailty: a two-sample Mendelian randomization study.
Feng J; Chen X; Cai W; Zhou X; Zhang X
Aging Clin Exp Res; 2024 Feb; 36(1):21. PubMed ID: 38319411
[TBL] [Abstract][Full Text] [Related]
13. Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease.
Miao XP; Li JS; Ouyang Q; Hu RW; Zhang Y; Li HY
Cochrane Database Syst Rev; 2014 Oct; (10):CD007744. PubMed ID: 25340915
[TBL] [Abstract][Full Text] [Related]
14. Cancer risk in patients with inflammatory bowel disease: a population-based study.
Bernstein CN; Blanchard JF; Kliewer E; Wajda A
Cancer; 2001 Feb; 91(4):854-62. PubMed ID: 11241255
[TBL] [Abstract][Full Text] [Related]
15. Association of Depression With Incident Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis.
Piovani D; Armuzzi A; Bonovas S
Inflamm Bowel Dis; 2024 Apr; 30(4):573-584. PubMed ID: 37300511
[TBL] [Abstract][Full Text] [Related]
16. Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.
Sinopoulou V; Gordon M; Akobeng AK; Gasparetto M; Sammaan M; Vasiliou J; Dovey TM
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD013531. PubMed ID: 34844288
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory bowel disease is associated with an increased risk of melanoma: a systematic review and meta-analysis.
Singh S; Nagpal SJ; Murad MH; Yadav S; Kane SV; Pardi DS; Talwalkar JA; Loftus EV
Clin Gastroenterol Hepatol; 2014 Feb; 12(2):210-8. PubMed ID: 23644389
[TBL] [Abstract][Full Text] [Related]
18. Risk of venous thromboembolism in children and adolescents with inflammatory bowel disease: A systematic review and meta-analysis.
Zhang XY; Dong HC; Wang WF; Zhang Y
World J Gastroenterol; 2022 Apr; 28(16):1705-1717. PubMed ID: 35581968
[TBL] [Abstract][Full Text] [Related]
19. A population- and family-based study of Canadian families reveals association of HLA DRB1*0103 with colonic involvement in inflammatory bowel disease.
Silverberg MS; Mirea L; Bull SB; Murphy JE; Steinhart AH; Greenberg GR; McLeod RS; Cohen Z; Wade JA; Siminovitch KA
Inflamm Bowel Dis; 2003 Jan; 9(1):1-9. PubMed ID: 12656131
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory bowel disease and risk of breast cancer: a meta-analysis of cohort studies.
Gong C; Xu R; Zou P; Zhang Y; Wang X
Eur J Cancer Prev; 2022 Jan; 31(1):54-63. PubMed ID: 34871199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
